Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Takeda reports novel carbapenems

Nov. 24, 1997

New triazole antifungals from Pfizer

Nov. 24, 1997

Floxin recommended for FDA approval

Nov. 21, 1997

AMBI cleared by FDA to commence nisin trials

Nov. 19, 1997

New antifungals from Pola

Nov. 19, 1997

Sankyo isolates A-76356, novel antibacterial agent

Nov. 19, 1997

MiKasome enters phase II for UTI

Nov. 18, 1997

Merck & Co. isolates novel antifungal agent with potent, broad-spectrum activity

Nov. 18, 1997

Inhibitors of viral neuraminidase from Biota

Nov. 17, 1997

Xoma reports phase II results of Neuprex in trauma patients

Nov. 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...